Warby Parker Inc. Class A (WRBY) is listed on NYSE in Medical Device Stocks. It is $25.00, -1.07%, with a $3.1B market cap. RSI is 46.2, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 46.2 Neutral
Market Cap $3.1B
P/E Ratio 416.7x
Volume 1.5M
Fundamentals — 10-Q Q2 2026
Revenue $478.0M
Net Income $7.8M
EPS $0.06
Gross Margin 56.0%
Operating Margin 1.0%
Net Margin 1.6%
P/E Ratio 416.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 9,200 | $29.99 | $275,908 | 2026 Jul 6 |
| Gilboa David Abraham | Co-Chief Executive Officer | Sell | 54,347 | $29.84 | $1.6M | 2026 Jul 6 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 217,667 | $29.61 | $6.4M | 2026 Jul 1 |
| Gilboa David Abraham | Co-Chief Executive Officer | Sell | 242,221 | $29.69 | $7.2M | 2026 Jul 1 |
| Raider Jeffrey Jacob | Director | Sell | 22,500 | $29.72 | $668,700 | 2026 Jul 1 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 36,300 | $30.04 | $1.1M | 2026 Jun 29 |
| Briggs Teresa | Director | Sell | 5,000 | $25.94 | $129,683 | 2026 Jun 16 |
| Moon Youngme E | Director | Sell | 10,000 | $26.53 | $265,300 | 2026 Jun 12 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 63,040 | $30.03 | $1.9M | 2026 May 19 |
| Singer Bradley E | Director | Sell | 25,000 | $28.61 | $715,167 | 2026 May 14 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 100,000 | $24.67 | $2.5M | 2026 Apr 20 |
| Raider Jeffrey Jacob | Director | Sell | 25,000 | $25.43 | $635,750 | 2026 Mar 11 |
| Singer Bradley E | Director | Sell | 15,793 | $27.53 | $434,781 | 2026 Mar 4 |
| Cutler Joel E | Director | Sell | 19,932 | $26.01 | $518,431 | 2025 Dec 16 |
| Raider Jeffrey Jacob | Director | Sell | 25,000 | $27.42 | $685,500 | 2025 Dec 12 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 100,000 | $30.29 | $3.0M | 2025 Dec 11 |
| Moon Youngme E | Director | Sell | 38,832 | $29.07 | $1.1M | 2025 Dec 11 |
| Gilboa David Abraham | Co-Chief Executive Officer | Sell | 200,000 | $30.20 | $6.0M | 2025 Dec 11 |
| Gilboa David Abraham | Co-Chief Executive Officer | Sell | 125,000 | $27.30 | $3.4M | 2025 Oct 1 |
| Blumenthal Neil Harris | Co-Chief Executive Officer | Sell | 8,916 | $27.52 | $245,368 | 2025 Sep 18 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $28.98 | 41.8 | -- |
| | $190.31 | 64.7 | $7.3B |
| | $8.44 | 51.9 | $2.2B |
Take WRBY further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put WRBY in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Warby Parker Inc. Class A next reports.
Set alerts on WRBY
Get notified when Warby Parker Inc. Class A hits your price targets or technical conditions are met.
Get Started Free